Financials

Annual Reports

Financial Reports

Fiscal Year First Quarter Second Quarter Third Quarter Information Circular Financials & MD&A Annual Report

Filings

SEDAR View our filings as a publicly listed company in Canada (TSX).

EDGAR Our SEC filings as a publicly listed company in the United States (NASDAQ).

Analyst Coverage

Find out which analysts and institutions provide coverage of Oncolytics.

View Analyst Coverage

Latest News

July 08, 2014 Oncolytics Biotech® Inc. Announces Completion of Patient Enrollment in U.S. Randomized Phase II Pancreatic Cancer Study
June 19, 2014 Oncolytics Biotech® Inc. Announces Director Election Results from its Annual Meeting of Shareholders
June 16, 2014 Oncolytics Biotech® Inc. Announces Details of 2014 Annual Meeting of Shareholders
Sign up to receive e-mail updates *